New Natural History Study Sheds Light on MNGIE

2 Sep, 2026

A new retrospective natural history study from the MitoCAMB team at the University of Cambridge offers important insights into mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), a rare but severe mitochondrial disorder. 

By analysing existing clinical records from individuals diagnosed with MNGIE, researchers aimed to build a clearer picture of how the disease progresses over time, which symptoms emerge earliest, and how different organ systems are affected. This type of natural history work is essential for improving diagnosis, guiding clinical management, and supporting future therapeutic development.

The study highlights the complexity of MNGIE, particularly its gastrointestinal, neurological and metabolic features, and reinforces the need for earlier recognition and coordinated specialist care. Findings will help clinicians better understand disease trajectories and contribute to more informed trial design for emerging treatments.